Healthcare Services

GI Stool Testing Market Outlook 2026–2030 with Major Growth Drivers and Emerging Industry Trends

April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Will The Market Size Of The GI Stool Testing Market Evolve From 2026 To 2030?

The gi stool testing market has experienced significant expansion in recent years. Its valuation is set to climb from $1.41 billion in 2025 to $1.51 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.4%. Factors such as the increase in gastrointestinal disorders, enhancements in diagnostic laboratories, the development of early microbiology testing, an upswing in colorectal cancer screening, and heightened healthcare awareness contributed to its historical growth.

The gi stool testing market size is projected to experience robust expansion over the coming years. This market is set to reach $1.99 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.1%. Key factors contributing to this anticipated growth include the increased availability of personalized gut health testing, the rise of home diagnostics, the incorporation of AI-based analysis, greater adoption of preventive healthcare, and heightened awareness of digestive health. Significant trends expected during this period involve an increasing preference for non-invasive diagnostics, a surge in the uptake of microbiome-based testing, broader application of molecular diagnostic methods, the proliferation of home-based stool testing kits, and enhanced early detection capabilities for GI disorders.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=23410&type=smp

What Major Drivers Are Influencing Demand In The GI Stool Testing Market?

The expanding occurrence of gastrointestinal conditions is projected to drive the future growth of the GI stool testing market. These disorders, which impact the digestive system including the stomach, intestines, and associated organs, manifest with symptoms such as nausea, diarrhea, constipation, and abdominal pain. The increase in gastrointestinal disorders largely stems from poor eating habits; a greater intake of processed foods, high sugar, and low-fiber diets disturbs gut microbiota, compromises digestive health, and contributes to conditions like acid reflux, irritable bowel syndrome (IBS), and inflammatory bowel disease (IBD). GI stool testing is essential for gastrointestinal disorders to identify infections, inflammation, or digestive imbalances. It aids in pinpointing pathogens (bacteria, viruses, parasites), indicators of gut inflammation, and deficiencies in digestive enzymes, facilitating precise diagnosis and targeted therapy. For example, in September 2024, the Centers for Disease Control and Prevention reported 1,676 norovirus outbreaks in NoroSTAT-participating states from 2024 to 2025, a substantial increase from the 729 outbreaks noted during the corresponding period last season. Consequently, the rising frequency of gastrointestinal disorders is a key driver for the GI stool testing market’s expansion.

Which Segment Areas Are Covered In The GI Stool Testing Market Analysis?

The gi stool testing market covered in this report is segmented –

1) By Type: Immunoassay Test, Molecular Diagnostic Test, Chromatography-Based Test, Microbiological Culture Test, Enzyme-Linked Immunosorbent Assay (ELISA)

2) By Sample Type: Fecal Samples, Serum Samples

3) By Equipment: Automated Analyzers, Benchtop Instruments, Portable Devices

4) By Application: Diagnosis Of Gastrointestinal Disorders, Screening For Colorectal Cancer, Monitoring Of Inflammatory Bowel Disease (IBD), Detection Of Gastrointestinal Infections, Evaluation Of Digestive Health

5) By End User: Hospital, Diagnostic Centre And Laboratory, Academic Institution, Research Centre Organization, Homecare, Other End Users

Subsegments:

1) By Immunoassay Test: Rapid Immunoassay, Lateral Flow Assay, Fluorescent Immunoassay

2) By Molecular Diagnostic Test: Polymerase Chain Reaction (PCR), Nucleic Acid Amplification Test (NAAT), Next-Generation Sequencing (NGS)

3) By Chromatography-Based Test: Gas Chromatography (GC), Liquid Chromatography (LC), Thin-Layer Chromatography (TLC)

4) By Microbiological Culture Test: Aerobic Culture, Anaerobic Culture, Selective Media Culture

5) By Enzyme-Linked Immunosorbent Assay (ELISA): Direct ELISA, Indirect ELISA, Sandwich ELISA, Competitive ELISA

Which Trends Are Influencing The GI Stool Testing Market?

Major companies operating in the GI stool testing market are prioritizing advanced testing technologies, such as comprehensive diagnostic tests, to enhance accuracy, speed, and early disease detection. A comprehensive diagnostic test serves as an advanced medical instrument that simultaneously evaluates multiple health parameters, offering a thorough assessment of a condition. For instance, in November 2024, EmeritusDX, a US-based diagnostics company, launched GI Detect, a comprehensive diagnostic test developed to assist healthcare providers in identifying gastrointestinal disorders. This cutting-edge test utilizes a single stool swab to detect 26 bacteria, viruses, and parasites associated with digestive system disruptions. With a 24-hour turnaround time, GI Detect facilitates fast and informed clinical decision-making. In addition to broad pathogen detection, the test also screens for Helicobacter pylori and its virulence factors VacA, cagA, and babA, along with common gastrointestinal parasites such as Cryptosporidium, Entamoeba histolytica, and Giardia lamblia. This comprehensive approach ensures accurate and timely diagnosis of gastrointestinal infections.

Which Global Companies Are Actively Competing In The GI Stool Testing Market?

Major companies operating in the gi stool testing market are Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Hologic Inc., Biomerieux SA, Bio-Rad Laboratories Inc., Meridian BioScience Inc., Diasorin SPA, ELITechGroup, Genova Diagnostics Inc., US BioTek Laboratories LLC, Doctor’s Data Inc., Diagnostic Solutions Laboratory LLC, Functional Medical Institute Pvt. Ltd., Walk-In Lab LLC, ScheBo Biotech AG, Qiagen NV, Roche Diagnostics, Siemens Healthineers, QuidelOrtho Corporation, Biohit Oyj, Exact Sciences Corporation

Read the full gi stool testing market report here:

https://www.thebusinessresearchcompany.com/report/gi-stool-testing-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The GI Stool Testing Market?

North America was the largest region in the GI stool testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gi stool testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored GI Stool Testing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=23410&type=smp

Browse Through More Reports Similar to the Global GI Stool Testing Market 2026, By The Business Research Company

Pompe Disease Global Market Report

https://www.thebusinessresearchcompany.com/report/pompe-disease-global-market-report

Ectopic Pregnancy Global Market Report

https://www.thebusinessresearchcompany.com/report/ectopic-pregnancy-global-market-report

Human Chorionic Gonadotropin Global Market Report

https://www.thebusinessresearchcompany.com/report/human-chorionic-gonadotropin-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795